Wolverine Trading’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $227K | Buy |
+28,600
| New | +$204K | ﹤0.01% | 4774 |
|
|
2025
Q1 | – | Sell |
-16,400
| Closed | -$154K | – | 5105 |
|
|
2024
Q4 | $154K | Sell |
16,400
-9,500
| -37% | -$98.7K | ﹤0.01% | 4659 |
|
|
2024
Q3 | $277K | Buy |
+25,900
| New | +$282K | ﹤0.01% | 3720 |
|
|
2024
Q1 | – | Sell |
-14,400
| Closed | -$204K | – | 4741 |
|
|
2023
Q4 | $204K | Sell |
14,400
-2,100
| -13% | -$23.8K | ﹤0.01% | 3853 |
|
|
2023
Q3 | $201K | Buy |
16,500
+6,500
| +65% | +$83.8K | ﹤0.01% | 3745 |
|
|
2023
Q2 | $126K | Buy |
+10,000
| New | +$119K | ﹤0.01% | 3702 |
|
|
2022
Q4 | – | Sell |
-15,300
| Closed | -$157K | – | 4315 |
|
|
2022
Q3 | $157K | Buy |
+15,300
| New | +$170K | ﹤0.01% | 3736 |
|
|
2021
Q3 | – | Sell |
-17,700
| Closed | -$176K | – | 6462 |
|
|
2021
Q2 | $176K | Sell |
17,700
-30,300
| -63% | -$296K | ﹤0.01% | 5102 |
|
|
2021
Q1 | $451K | Buy |
48,000
+31,800
| +196% | +$492K | ﹤0.01% | 3856 |
|
|
2020
Q4 | $372K | Sell |
16,200
-6,400
| -28% | -$131K | ﹤0.01% | 3500 |
|
|
2020
Q3 | $318K | Sell |
22,600
-16,300
| -42% | -$238K | ﹤0.01% | 3327 |
|
|
2020
Q2 | $605K | Sell |
38,900
-400
| -1% | -$4.87K | ﹤0.01% | 2531 |
|
|
2020
Q1 | $382K | Buy |
39,300
+1,700
| +5% | +$16.2K | ﹤0.01% | 2950 |
|
|
2019
Q4 | $358K | Sell |
37,600
-4,100
| -10% | -$37.5K | ﹤0.01% | 3389 |
|
|
2019
Q3 | $336K | Sell |
41,700
-9,300
| -18% | -$101K | ﹤0.01% | 3047 |
|
|
2019
Q2 | $636K | Buy |
51,000
+29,200
| +134% | +$371K | ﹤0.01% | 2471 |
|
|
2019
Q1 | $296K | Sell |
21,800
-2,000
| -8% | -$24.4K | ﹤0.01% | 3368 |
|
|
2018
Q4 | $220K | Sell |
23,800
-64,100
| -73% | -$705K | ﹤0.01% | 3593 |
|
|
2018
Q3 | $1.06M | Sell |
87,900
-41,700
| -32% | -$583K | ﹤0.01% | 2291 |
|
|
2018
Q2 | $1.95M | Hold |
129,600
| – | – | ﹤0.01% | 1616 |
|
|
2018
Q1 | $1.95M | Buy |
129,600
+63,400
| +96% | +$965K | ﹤0.01% | 1616 |
|
|
2017
Q4 | $953K | Sell |
66,200
-5,500
| -8% | -$75.6K | ﹤0.01% | 2256 |
|
|
2017
Q3 | $1.08M | Sell |
71,700
-800
| -1% | -$10.6K | ﹤0.01% | 1846 |
|
|
2017
Q2 | $720K | Buy |
72,500
+26,200
| +57% | +$211K | ﹤0.01% | 2062 |
|
|
2017
Q1 | $334K | Buy |
46,300
+4,500
| +11% | +$28.5K | ﹤0.01% | 2890 |
|
|
2016
Q4 | $208K | Sell |
41,800
-4,900
| -10% | -$33.9K | ﹤0.01% | 3725 |
|
|
2016
Q3 | $330K | Buy |
46,700
+12,600
| +37% | +$85.1K | ﹤0.01% | 3098 |
|
|
2016
Q2 | $185K | Buy |
+34,100
| New | +$238K | ﹤0.01% | 3333 |
|
Other funds holding FOLD
ACA
VPC
Wolverine Trading's FOLD Position: Q3 2025 in Review
Wolverine Trading reduced its Amicus Therapeutics (FOLD) stake by 57% in Q3 2025, selling an estimated $107K and leaving 11,399 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5231.
Wolverine Trading first reported a position in FOLD in Q4 2016 and has held it in 21 quarters since. The position peaked at $640K in Q3 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.
- Wolverine Trading held 11,399 shares of Amicus Therapeutics worth $90.5K as of Q3 2025.
- Wolverine Trading sold 15,039 Amicus Therapeutics shares in Q3 2025, an estimated $107K.
- Amicus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5231 holding.
- Wolverine Trading first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 21 quarters since.
- Wolverine Trading's Amicus Therapeutics position peaked at $640K in Q3 2024.
- 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.